The retina has been increasingly investigated as a site of Alzheimer's disease (AD)
manifestation for over a decade. Early reports documented degeneration of retinal ganglion …

The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

Alzheimer's disease (AD) pathologies were discovered in the accessible neurosensory
retina. However, their exact nature and topographical distribution, particularly in the early …

This paper presents the first challenge on demosaicing of natural spectral images for
snapshot hyperspectral imaging systems (HIS) which utilize a multi-spectral filer array …

There is emerging evidence that amyloid beta protein (Aβ) and tau‐related lesions in the
retina are associated with Alzheimer's disease (AD). Aβ and hyperphosphorylated (p)‐tau …

Alzheimer's disease (AD) is a major risk for the aging population. The pathological hallmarks
of AD—an abnormal deposition of amyloid β-protein (Aβ) and phosphorylated tau (pTau) …

Machine learning models that can accurately distinguish those with symptomatic Alzheimer's
dementia from those with mild cognitive impairment and normal cognition as well as predict …

The relationship between amyloidosis and vasculature in cognitive impairment and
Alzheimer's disease (AD) pathogenesis is increasingly acknowledged. We conducted a …

Retinal neurodegeneration and visual dysfunctions have been reported in a majority of
Alzheimer's and Parkinson's patients, and, in light of the quest for novel biomarkers for these …

The timely detection of neurodegenerative diseases is central to improving clinical care as
well as enabling the development and deployment of disease-modifying therapies. Retinal …